- Norway | 19 November 2020
What were the key experiences you were able to bring to Epiguard?
The most important experiences I brought to Epiguard were my knowledge of the market from both a sales and regulatory perspective, as well as my experience in building a company. Working in large international corporations like Praxair and AbbVie taught me the importance of systems and structure, which is crucial when building a small company into an international success. Additionally, my background in marketing and sales, gained from both corporate firms and early experiences in the market, has been valuable for Epiguard.
Could you tell our readership about Epiguard’s main product, EpiShuttle?
The main product of Epiguard is the EpiShuttle. It was developed in response to the need for improved equipment for transporting highly infectious patients. Existing products were found to be lacking in terms of air and liquid tightness, posing risks to healthcare professionals. The EpiShuttle was designed to be completely airtight and incorporates filters to ensure the safety of medical professionals. It allows for proper medical treatment during transport with features like airway access holes, ports for full body access, a sluice bag for medication, medical ports for IV lines, and a ventilator sleeve for intensive care patients. Epiguard also offers courses and training to healthcare professionals to enhance their skills and plans to develop new products in the future.
Who are Epiguard’s main clients?
Epiguard’s main clients currently include national healthcare systems, international organizations involved in repatriating patients with infectious diseases, military organizations, and ambulance services. The COVID-19 pandemic has also led to an increased adoption of the EpiShuttle by air ambulance services. The product allows for safe transportation of patients and reduces the need for healthcare workers to wear personal protective equipment, thus preventing fatigue. In the future, Epiguard sees potential for the EpiShuttle in isolating patients with biological or chemical hazards and even in the tourism industry, such as transporting patients from cruise ships to onshore hospitals.
What are the advantages of being based in Norway?
Norway offers several advantages for Epiguard. The government recognizes the importance of innovation in job creation and strengthening the economy. The country has an excellent healthcare system and a highly educated population, providing access to skilled individuals. Culturally, Norway is open to adopting new technologies and processes, which has helped Epiguard find reference customers and receive valuable feedback. However, challenges arise from the early development stage of Norway’s healthcare industry compared to neighboring countries like Sweden and Denmark.
Where will Epiguard be in five years?
In five years, we envision Epiguard being established in numerous markets worldwide. Our goal is to have a strong presence in Asian markets, the US market, and all five major markets in Europe. We also aim to expand our product portfolio and become a significant partner for organizations involved in transporting highly infectious patients.
What advice would you give to someone wanting to change their career?
I would advise anyone looking to change their career to embrace curiosity and a willingness to learn new things. It’s important to be flexible and open to trying new approaches. Seeing things from different perspectives can be invaluable, and having prior experience in the healthcare system can provide insights into patient needs and the perspective of healthcare professionals. Being adaptable and having a broader view can help understand the benefits of new innovations and avoid short-term cost-saving measures that may prove more expensive in the long run. Previous experiences can provide a solid foundation for future career endeavors.